Rafferty Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Rafferty Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-58,576	Closed	-$1.71M	–	1174
2022 Q4	$1.71M	Buy	58,576 +1,272	+2%	+$40.4K	0.01%	616
2022 Q3	$1.51M	Buy	57,304 +36,475	+175%	+$1.34M	0.02%	571
2022 Q2	$925K	Sell	20,829 -8,045	-28%	-$370K	0.01%	677
2022 Q1	$1.43M	Sell	28,874 -3,421	-11%	-$164K	0.01%	702
2021 Q4	$1.64M	Buy	32,295 +13,177	+69%	+$683K	0.01%	731
2021 Q3	$1.07M	Sell	19,118 -2,136	-10%	-$105K	0.01%	796
2021 Q2	$910K	Sell	21,254 -9,955	-32%	-$411K	0.01%	950
2021 Q1	$1.3M	Buy	31,209 +23,697	+315%	+$1.1M	0.01%	711
2020 Q4	$350K	Sell	7,512 -11,828	-61%	-$553K	﹤0.01%	771
2020 Q3	$822K	Buy	19,340 +10,692	+124%	+$468K	0.01%	606
2020 Q2	$415K	Buy	+8,648	New	+$431K	0.01%	754
2020 Q1	–	Sell	-16,144	Closed	-$970K	–	833
2019 Q4	$970K	Sell	16,144 -7,858	-33%	-$469K	0.01%	561
2019 Q3	$1.36M	Sell	24,002 -10,324	-30%	-$581K	0.02%	474
2019 Q2	$1.91M	Buy	34,326 +7,846	+30%	+$409K	0.03%	429
2019 Q1	$1.34M	Buy	+26,480	New	+$1.18M	0.02%	495
2017 Q4	–	Sell	-12,985	Closed	-$774K	–	742
2017 Q3	$774K	Buy	+12,985	New	+$786K	0.02%	446

Other funds holding EGRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rafferty Asset Management's EGRX Position: Q1 2023 in Review

Rafferty Asset Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2023, closing a stake of 58,576 shares — an estimated $1.71M sold.

Rafferty Asset Management first reported a position in EGRX in Q3 2017 and held it in 16 quarters. The position peaked at $1.91M in Q2 2019. 153 funds tracked by Wall St. Rank hold EGRX as of Q1 2023.

Rafferty Asset Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Rafferty Asset Management sold 58,576 Eagle Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.71M.
Rafferty Asset Management first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2017 and held it in 16 quarters.
Rafferty Asset Management's Eagle Pharmaceuticals, Inc. position peaked at $1.91M in Q2 2019.
153 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2023.

Based on Rafferty Asset Management's 13F filing for Q1 2023, filed 11 May 2023.